arrow_back Trending Legislation
Share share

Improved Access to Non-Opioid Pain Treatments in Hospitals

This act aims to improve access to non-opioid pain treatments in hospital outpatient and ambulatory surgical settings, potentially helping to combat the opioid crisis. Citizens will have a wider range of non-addictive pain management options, with Medicare providing separate payments for these treatments. Additionally, the act mandates a report on barriers to other pain therapies, which could lead to future improvements.
Key points
Separate Medicare payments for non-opioid drugs and medical devices for pain treatment in hospital outpatient settings from 2022 to 2027.
Similar separate payments for non-opioid pain treatments in ambulatory surgical centers during the same period.
Report to Congress on barriers to access for other pain therapies (e.g., behavioral, complementary) under Medicare, excluding non-opioid drugs and devices.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
NOPAIN Act
Print number: S 586
Sponsor: Sen. Capito, Shelley Moore [R-WV]
Process start date: 2021-03-04
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Improved Access to Non-Opioid Pain Treatments in Hospitals

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 586.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-03-04.

What are the main provisions?

Key points include:

  • Separate Medicare payments for non-opioid drugs and medical devices for pain treatment in hospital outpatient settings from 2022 to 2027.
  • Similar separate payments for non-opioid pain treatments in ambulatory surgical centers during the same period.
  • Report to Congress on barriers to access for other pain therapies (e.g., behavioral, complementary) under Medicare, excluding non-opioid drugs and devices.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Capito, Shelley Moore [R-WV].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-02.

Analysis and Potential Impact of S 586

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health